Skip to main content

Diagnostic options · UAE

Ehlers-Danlos Syndrome tests in Dubai & UAE

Compare available Ehlers-Danlos Syndrome tests, their listed prices and the information provided for each option. Test selection and preparation should be discussed with your clinician.

Tests in this category

7

Listed price range

2,800.00 AED

Clinical preparation

Confirm test-specific instructions with your clinician or laboratory.

Compare available tests

Ehlers-Danlos Syndrome test prices

Showing 1–7 of 7 matching tests.

Ehlers-Danlos Syndrome diagnostic tests, details, and listed prices
Test and description Specimen Typical duration Price Options
TEST-5145
B3GALT6 Gene Sequencing for Ehlers-Danlos Syndrome, Progeroid Type 2 (NGS) Test

This test identifies pathogenic variants in the B3GALT6 gene associated with Ehlers-Danlos Syndrome, progeroid type 2 (EDSP2).

Peripheral Whole Blood 3–4 Weeks 2,800.00 AED
View
View test specifications and preparation
What it measures
["Biallelic pathogenic variants in the B3GALT6 gene"]
Parameters
[]
Preparation
["No fasting required", "Inform phlebotomist of bleeding disorder or anticoagulant use"]
Indications
["Clinical suspicion of Ehlers-Danlos Syndrome, progeroid type 2 (EDSP2)"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 57903-0 ICD-10: Q79.6
Clinical summary
This test identifies pathogenic variants in the B3GALT6 gene associated with Ehlers-Danlos Syndrome, progeroid type 2 (EDSP2).
TEST-5191
CHST14 Gene Ehlers-Danlos Syndrome, Musculocontractural Type 1 Genetic Test

This genetic test identifies pathogenic variants in the CHST14 gene associated with Ehlers-Danlos Syndrome, musculocontractural type 1.

Whole Blood (EDTA tube), Extracted DNA (≥50 ng/µL), or FTA Card (single drop) 3 to 4 Weeks 2,800.00 AED
View
View test specifications and preparation
What it measures
["Pathogenic variants in the CHST14 gene", "Single nucleotide variants", "Small insertions or deletions", "Splice-site mutations"]
Parameters
[]
Preparation
["A detailed clinical history of the patient is required", "A genetic counselling session is mandatory to draw a pedigree chart"]
Indications
["Suspected diagnosis of Ehlers-Danlos Syndrome, musculocontractural type 1", "Family history of mcEDS-CHST14", "Genetic counselling for at-risk families"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 86294-4 ICD-10: Q79.6, Z15.89, Z84.81
Clinical summary
This genetic test identifies pathogenic variants in the CHST14 gene associated with Ehlers-Danlos Syndrome, musculocontractural type 1.
TEST-5197
COL1A1 Gene Ehlers-Danlos Syndrome Type VIIA Genetic Test

This test identifies pathogenic variants in the COL1A1 gene associated with Ehlers-Danlos syndrome type VIIA (arthrochalasia type).

Peripheral Whole Blood 3 to 4 Weeks 2,800.00 AED
View
View test specifications and preparation
What it measures
["Pathogenic variants in COL1A1 gene", "Copy Number Variants (CNV) in COL1A1 gene"]
Parameters
[]
Preparation
["No fasting necessary", "Mandatory pre-test genetic counselling session (telephone or in-person)"]
Indications
["Suspected Ehlers-Danlos syndrome type VIIA (arthrochalasia type)", "Family history of EDS type VIIA", "Need for genetic counselling and cascade testing"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 21625-4 ICD-10: Q79.6
Clinical summary
This test identifies pathogenic variants in the COL1A1 gene associated with Ehlers-Danlos syndrome type VIIA (arthrochalasia type).
TEST-5163
COL3A1 Gene Ehlers-Danlos Syndrome Type 4 (vEDS) Genetic Test

This test identifies pathogenic mutations in the COL3A1 gene, confirming a diagnosis of vascular Ehlers-Danlos syndrome (vEDS).

Peripheral Whole Blood, Extracted DNA, or FTA Card Spot 3–4 weeks 2,800.00 AED
View
View test specifications and preparation
What it measures
["COL3A1 gene mutations", "Pathogenic variants"]
Parameters
[]
Preparation
["No fasting required"]
Indications
["Suspected vascular Ehlers-Danlos syndrome", "Family history of vEDS", "Clinical features suggestive of vEDS"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 21643-2 ICD-10: Q79.6
Clinical summary
This test identifies pathogenic mutations in the COL3A1 gene, confirming a diagnosis of vascular Ehlers-Danlos syndrome (vEDS).
TEST-5202
COL5A1 Genetic NGS Screening for Vascular Ehlers‑Danlos Syndrome (vEDS) Test

This test identifies pathogenic variants within the COL5A1 gene associated with Vascular Ehlers‑Danlos Syndrome (vEDS).

Peripheral whole blood (3–5 mL in EDTA tube), extracted genomic DNA, or FTA card 3–4 weeks 2,800.00 AED
View
View test specifications and preparation
What it measures
["COL5A1 gene sequence", "Copy Number Variants (CNVs) in COL5A1"]
Parameters
[]
Preparation
["No specific fasting required", "Inform lab of any medications"]
Indications
["Suspected diagnosis of Vascular Ehlers‑Danlos Syndrome (vEDS)", "Family history of vEDS", "Pre-surgical screening for individuals with connective tissue disorder symptoms"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 94301-2 ICD-10: Q79.6
Clinical summary
This test identifies pathogenic variants within the COL5A1 gene associated with Vascular Ehlers‑Danlos Syndrome (vEDS).
TEST-5159
PLOD1 Gene Ehlers-Danlos Syndrome Type 6 Genetic Test

This genetic test identifies pathogenic variants in the PLOD1 gene associated with Ehlers-Danlos syndrome type 6.

Whole blood (EDTA), extracted DNA, or dried blood spot (FTA card) 3–4 weeks 2,800.00 AED
View
View test specifications and preparation
What it measures
["Pathogenic variants in the PLOD1 gene"]
Parameters
[]
Preparation
[]
Indications
["Suspected Ehlers-Danlos syndrome type 6", "Family screening for PLOD1 mutations", "Diagnosis of kyphoscoliotic EDS"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 94829-6 ICD-10: Q79.62
Clinical summary
This genetic test identifies pathogenic variants in the PLOD1 gene associated with Ehlers-Danlos syndrome type 6.
TEST-5204
TNXB Gene Ehlers-Danlos Syndrome Type 3 Genetic Test

This test evaluates the TNXB gene for pathogenic variants associated with classical-like Ehlers-Danlos syndrome (clEDS). It identifies mutations causing tenascin-X deficiency.

Whole blood, extracted DNA, FTA card 3–4 weeks 2,800.00 AED
View
View test specifications and preparation
What it measures
["Pathogenic variants in the TNXB gene", "Single nucleotide variants (SNVs)", "Small indels", "Copy number variations (CNVs)"]
Parameters
[]
Preparation
[]
Indications
["Clinical suspicion of classical-like Ehlers-Danlos syndrome (clEDS)", "Family history of EDS", "Genetic counseling for inherited connective tissue disorders"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 100309-3 ICD-10: Q79.6
Clinical summary
This test evaluates the TNXB gene for pathogenic variants associated with classical-like Ehlers-Danlos syndrome (clEDS). It identifies mutations causing tenascin-X deficiency.

Category overview

Ehlers-Danlos Syndrome: overview

Coping with extreme joint hypermobility, fragile skin, or unexplained chronic pain requires proactive, overarching insights to protect your structural health and prevent severe complications. Within our advanced Genetics services, testing for Ehlers-Danlos Syndrome (EDS) maps your DNA for inherited mutations that weaken the body's essential collagen and connective tissues. Utilizing cutting-edge sequencing technology, this expansive molecular screening helps identify the exact subtype of EDS—including critical vascular variants—safely guiding your healthcare provider in tailoring highly personalized orthopedic care, cardiovascular monitoring, and preventative physical therapies. Widely respected for specialized diagnostic excellence among top diagnostic labs in the UAE, DNA Labs ensures absolute patient confidentiality, exceptional analytical accuracy, and prompt, reliable turnaround times. Safeguard your body's vital scaffolding—schedule your Ehlers-Danlos syndrome testing in UAE, coordinate a comfortable home sample collection, or reach out to our expert medical team today.

Before booking

Use the test details as a conversation starter

The right diagnostic option depends on your reason for testing and individual circumstances. Check the listed specimen and timing, then confirm any preparation requirements with the ordering clinician or laboratory before collection.